Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have another exclusive interview from the ADA 2018 in Orlando.
Viswanathan Mohan, PhD, MD, DSc is the chairman of Dr. Mohan’s Diabetes Specialties Centre and president and director of the Madras Diabetes Research Foundation in Chennai, India. Dr. Mohan’s centre is a WHO Collaborating Centre for Noncommunicable Diseases Prevention and Control and IDF Centre of Excellence in Diabetes Care. The research foundation is an ICMR Centre for Advanced Research on Diabetes.
A student of Madras Medical College, Dr. Mohan was awarded the Dr. R.V. Rajam Gold Medal for standing first in the University of Madras in M.D. (General Medicine). Deeply interested in research from his undergraduate days, Dr. Mohan has published over 1,150 papers in peer-reviewed journals, including 720 original articles, 241 review articles and invited editorials, and 151 chapters to text-books on Diabetes and Internal Medicine. His work has received over 51,000 citations. Dr. Mohan has received over 160 awards, including the prestigious Dr. B.C. Roy National Award by the Medical Council of India and Dr. B. R. Ambedkar Centenary Award from the Indian Council of Medical Research, the highest award for Biomedical research in India. Recently he has been conferred with the prestigious Harold Rifkin Distinguished International Service in the Cause of Diabetes Award by the American Diabetes Association for his pioneering work in the field of diabetes and he is the first Indian to receive this award. Dr. Mohan also provides lifelong free treatment to thousands of poor patients through the free diabetic clinics established by him and has conducted over 2,500 free diabetes camps, including several along with the Sri Sathya Sai Organization. For his extensive contribution in the field of diabetes in 2012, Dr. Mohan was awarded the prestigious Padma Shri, from the Govt. of India.
Featured videos include:
or view the complete interview here: Full Interview.